Are you over 18 and want to see adult content?
More Annotations
A complete backup of https://origines-parfums.com
Are you over 18 and want to see adult content?
A complete backup of https://sydneybuildexpo.com
Are you over 18 and want to see adult content?
A complete backup of https://rocalibros.com
Are you over 18 and want to see adult content?
A complete backup of https://anphatravel.com
Are you over 18 and want to see adult content?
A complete backup of https://linuxbsdos.com
Are you over 18 and want to see adult content?
A complete backup of https://climateaction.org
Are you over 18 and want to see adult content?
A complete backup of https://physoc.org
Are you over 18 and want to see adult content?
A complete backup of https://johnnylawmotors.com
Are you over 18 and want to see adult content?
A complete backup of https://utopiamanagement.com
Are you over 18 and want to see adult content?
A complete backup of https://4vcadtpsib.ga
Are you over 18 and want to see adult content?
A complete backup of https://mixdrop.co
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of badgirlsblog.com
Are you over 18 and want to see adult content?
A complete backup of www.enf-cmnf.com
Are you over 18 and want to see adult content?
A complete backup of www.aerisdies.com
Are you over 18 and want to see adult content?
A complete backup of www.www.blackboyaddictionz.com
Are you over 18 and want to see adult content?
A complete backup of www.extasycams.com
Are you over 18 and want to see adult content?
Text
SAFETY INFORMATION
Review our indications and safety information to ensure the safe operation and use of the Eversense CGM System for continuous bloodglucose monitoring.
FIND AN AUTHORIZED PROVIDER Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. TRAINING PROGRAM AND CERTIFICATION The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. EVERSENSE CGM QUICK REFERENCE GUIDE The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. QUICK REFERENCE GUIDE Cautions (continued) • If the sensor, insertion site or smart transmitter feels warm, remove the smart transmitter immediately and contact your health care provider for further advice. A warm sensor could mean there is an infection or a sensor malfunction and should beremoved.
EVERSENSE® CGM SYSTEM DISTRIBUTOR LIST MKT-001489 rev 1 . To place your order, check order status and billing questions, please contact your distributor directly. Below please find our distributor contact list. EVERSENSE DATA MANAGEMENT SYSTEM (DMS) USER GUIDE The Eversense DMS is a web-based application that lets you see the big picture—with automatic uploads from your mobile app. It stores your data and offers detailed reports to show trends and patterns over time¹. 1. The Eversense Data Management System does not provide medical advice. Changes to your treatment plan should only be made by your health care provider. CODING AND BILLING QUICK REFERENCE GUIDE Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. EVERSENSE PLACEMENT AND REMOVAL TRAINING VIDEOS Learn how to place a new Eversense Sensor and remove a previous sensor. This video gives you step-by-step guidance, along with best practices for placement, closure and removal techniques. EVERSENSE CONTINUOUS GLUCOSE MONITORING Important Update: August 10, 2020. Senseonics announces agreement to collaborate with Ascensia Diabetes Care. Today we announced the signing of a collaboration and commercialization agreement between Senseonics, Incorporated, maker of the Eversense® brand of continuous glucose monitoring systems, and Ascensia Diabetes Care (Ascensia), maker of the CONTOUR® portfolio ofSAFETY INFORMATION
Review our indications and safety information to ensure the safe operation and use of the Eversense CGM System for continuous bloodglucose monitoring.
FIND AN AUTHORIZED PROVIDER Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. TRAINING PROGRAM AND CERTIFICATION The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. EVERSENSE CGM QUICK REFERENCE GUIDE The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. QUICK REFERENCE GUIDE Cautions (continued) • If the sensor, insertion site or smart transmitter feels warm, remove the smart transmitter immediately and contact your health care provider for further advice. A warm sensor could mean there is an infection or a sensor malfunction and should beremoved.
EVERSENSE® CGM SYSTEM DISTRIBUTOR LIST MKT-001489 rev 1 . To place your order, check order status and billing questions, please contact your distributor directly. Below please find our distributor contact list. EVERSENSE DATA MANAGEMENT SYSTEM (DMS) USER GUIDE The Eversense DMS is a web-based application that lets you see the big picture—with automatic uploads from your mobile app. It stores your data and offers detailed reports to show trends and patterns over time¹. 1. The Eversense Data Management System does not provide medical advice. Changes to your treatment plan should only be made by your health care provider. CODING AND BILLING QUICK REFERENCE GUIDE Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. EVERSENSE PLACEMENT AND REMOVAL TRAINING VIDEOS Learn how to place a new Eversense Sensor and remove a previous sensor. This video gives you step-by-step guidance, along with best practices for placement, closure and removal techniques.APP COMPATIBILITY
View compatibility requirements here for the Eversense Mobile App and Data Management System. Check if your device is compatible for continuous glucose monitoring (CGM). PATENTS | EVERSENSE CONTINUOUS GLUCOSE MONITORING The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. END-USER LICENSE AGREEMENT View the End-User License Agreement for patients and non-patients that use software for the Eversense Continuous Glucose Monitoring System. TRAINING, LEARNING, CLINICAL PRACTICE To begin learning about being an authorized Eversense CGM provider, see details about the five steps that include training, patient scheduling, and product ordering. PATENTS | SENSEONICS Disclaimer. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in yourcountry.
EVERSENSE DISTRIBUTION PARTNERS Disclaimer. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in yourcountry.
HEALTH CARE PROVIDER USER GUIDES Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. EVERSENSE USER GUIDES Disclaimer. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in yourcountry.
TAKE HOME INSTRUCTIONS Incision care for proper healing • Do not swim or soak in a tub for five days • Avoid strenuous activities that may pull at the incision or cause a lot of sweating around theCOMPATIBILITY
To help ensure an optimal experience with your Eversense system, we recommend you disable automatic updates on your mobile device. Some operating system updates may result in a need for a supporting update to the Eversense Mobile Apps. EVERSENSE CONTINUOUS GLUCOSE MONITORING Important Update: August 10, 2020. Senseonics announces agreement to collaborate with Ascensia Diabetes Care. Today we announced the signing of a collaboration and commercialization agreement between Senseonics, Incorporated, maker of the Eversense® brand of continuous glucose monitoring systems, and Ascensia Diabetes Care (Ascensia), maker of the CONTOUR® portfolio ofSAFETY INFORMATION
The Eversense CGM System is indicated for continually measuring glucose levels in adults (18 years and older) with diabetes for up to 90 days. It is designed to replace blood glucose testing for diabetes treatment decisions. The system is intended to: Provide real-time glucose readings. Provide glucose trend information. CONTACT US | EVERSENSE CONTINUOUS GLUCOSE MONITORING Contact us if you have questions/comments/concerns about the Eversense Continuous Glucose Monitoring System, our technology, or datamanagement.
FIND AN AUTHORIZED PROVIDER Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products.APP COMPATIBILITY
Some operating system updates may result in a need for a supporting update to the Eversense Mobile Apps. Once we have verified compatibility of new operating systems with Eversense, we will post them to this web page. Additionally, we recommend not using betaversions of
EVERSENSE XL
Eversense XL is the world’s first long-term CGM, with exceptional accuracy and a fully implantable sensor that lasts for up to 180 days. It can help you better manage your diabetes 1 by providing real-time insight into your changing glucose levels, which you can discreetly check on your compatible mobile device. People using Eversense say it helps them feel more confident about EVERSENSE CGM QUICK REFERENCE GUIDE The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. CODING AND BILLING QUICK REFERENCE GUIDE Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. TRAINING PROGRAM AND CERTIFICATION The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. QUICK REFERENCE GUIDE Cautions (continued) • If the sensor, insertion site or smart transmitter feels warm, remove the smart transmitter immediately and contact your health care provider for further advice. A warm sensor could mean there is an infection or a sensor malfunction and should beremoved.
EVERSENSE CONTINUOUS GLUCOSE MONITORING Important Update: August 10, 2020. Senseonics announces agreement to collaborate with Ascensia Diabetes Care. Today we announced the signing of a collaboration and commercialization agreement between Senseonics, Incorporated, maker of the Eversense® brand of continuous glucose monitoring systems, and Ascensia Diabetes Care (Ascensia), maker of the CONTOUR® portfolio ofSAFETY INFORMATION
The Eversense CGM System is indicated for continually measuring glucose levels in adults (18 years and older) with diabetes for up to 90 days. It is designed to replace blood glucose testing for diabetes treatment decisions. The system is intended to: Provide real-time glucose readings. Provide glucose trend information. CONTACT US | EVERSENSE CONTINUOUS GLUCOSE MONITORING Contact us if you have questions/comments/concerns about the Eversense Continuous Glucose Monitoring System, our technology, or datamanagement.
FIND AN AUTHORIZED PROVIDER Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products.APP COMPATIBILITY
Some operating system updates may result in a need for a supporting update to the Eversense Mobile Apps. Once we have verified compatibility of new operating systems with Eversense, we will post them to this web page. Additionally, we recommend not using betaversions of
EVERSENSE XL
Eversense XL is the world’s first long-term CGM, with exceptional accuracy and a fully implantable sensor that lasts for up to 180 days. It can help you better manage your diabetes 1 by providing real-time insight into your changing glucose levels, which you can discreetly check on your compatible mobile device. People using Eversense say it helps them feel more confident about EVERSENSE CGM QUICK REFERENCE GUIDE The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. CODING AND BILLING QUICK REFERENCE GUIDE Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. TRAINING PROGRAM AND CERTIFICATION The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. QUICK REFERENCE GUIDE Cautions (continued) • If the sensor, insertion site or smart transmitter feels warm, remove the smart transmitter immediately and contact your health care provider for further advice. A warm sensor could mean there is an infection or a sensor malfunction and should beremoved.
EVERSENSE XL
Eversense XL is the world’s first long-term CGM, with exceptional accuracy and a fully implantable sensor that lasts for up to 180 days. It can help you better manage your diabetes 1 by providing real-time insight into your changing glucose levels, which you can discreetly check on your compatible mobile device. People using Eversense say it helps them feel more confident about EVERSENSE USER GUIDES The Eversense DMS is a web-based application that lets you see the big picture—with automatic uploads from your mobile app. It stores your data and offers detailed reports to show trends and patterns over time¹. 1. The Eversense Data Management System does not providemedical advice.
END-USER LICENSE AGREEMENT Patients of Senseonics Products and Services . If you are a patient utilizing Senseonics Products and Services, please note that you must obtain certain Senseonics continuous glucose monitoring (CGM) equipment (“ Equipment ”) from a healthcare provider or supplier pursuant to a valid prescription. The Software you are using (forexample
EVERSENSE USER GUIDES Eversense XL CGM User Guide - British English, UK. Click here to download the latest version. Archive: Mar 2019 Archive.pdf. Oct 2018 Archive.pdf. Feb 2018 Archive - 2.pdf. Feb 2018 Archive - 1.pdf. Sep 2017 Archive.pdf. Aug 2017 Archive.pdf. TRAINING, LEARNING, CLINICAL PRACTICE step-two-block step-one-title. Through a series of online videos, staff and physicians learn about the insertion and removal procedures and how to create a sterile field for the Eversense CGM System. Training is less than 30 minutes. VIDEO. HEALTH CARE PROVIDER USER GUIDES Eversense Insertion and Remove Instruction. Review this step-by-step guide on how to place and remove an Eversense sensor. After appropriate training, in office sensor placement takes less than 15 minutes. Physicians, nurse practitioners and physicians’ assistants can all receive training. Download. EVERSENSE® CGM SYSTEM DISTRIBUTOR LIST MKT-001489 rev 1 . To place your order, check order status and billing questions, please contact your distributor directly. Below please find our distributor contact list. EVERSENSE PLACEMENT AND REMOVAL TRAINING VIDEOS Learn how to place a new Eversense Sensor and remove a previous sensor. This video gives you step-by-step guidance, along with best practices for placement, closure and removal techniques. TAKE HOME INSTRUCTIONS Incision care for proper healing • Do not swim or soak in a tub for five days • Avoid strenuous activities that may pull at the incision or cause a lot of sweating around the EVERSENSE DATA MANAGEMENT SYSTEM (DMS) USER GUIDE The Eversense DMS is a web-based application that lets you see the big picture—with automatic uploads from your mobile app. It stores your data and offers detailed reports to show trends and patterns over time¹. 1. The Eversense Data Management System does not provide medical advice. Changes to your treatment plan should only be made by your health care provider. EVERSENSE CONTINUOUS GLUCOSE MONITORING Important Update: August 10, 2020. Senseonics announces agreement to collaborate with Ascensia Diabetes Care. Today we announced the signing of a collaboration and commercialization agreement between Senseonics, Incorporated, maker of the Eversense® brand of continuous glucose monitoring systems, and Ascensia Diabetes Care (Ascensia), maker of the CONTOUR® portfolio ofSAFETY INFORMATION
The Eversense CGM System is indicated for continually measuring glucose levels in adults (18 years and older) with diabetes for up to 90 days. It is designed to replace blood glucose testing for diabetes treatment decisions. The system is intended to: Provide real-time glucose readings. Provide glucose trend information. CONTACT US | EVERSENSE CONTINUOUS GLUCOSE MONITORING Contact us if you have questions/comments/concerns about the Eversense Continuous Glucose Monitoring System, our technology, or datamanagement.
FIND AN AUTHORIZED PROVIDER Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products.APP COMPATIBILITY
Some operating system updates may result in a need for a supporting update to the Eversense Mobile Apps. Once we have verified compatibility of new operating systems with Eversense, we will post them to this web page. Additionally, we recommend not using betaversions of
EVERSENSE XL
Eversense XL is the world’s first long-term CGM, with exceptional accuracy and a fully implantable sensor that lasts for up to 180 days. It can help you better manage your diabetes 1 by providing real-time insight into your changing glucose levels, which you can discreetly check on your compatible mobile device. People using Eversense say it helps them feel more confident about EVERSENSE CGM QUICK REFERENCE GUIDE The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. CODING AND BILLING QUICK REFERENCE GUIDE Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. TRAINING PROGRAM AND CERTIFICATION The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. QUICK REFERENCE GUIDE Cautions (continued) • If the sensor, insertion site or smart transmitter feels warm, remove the smart transmitter immediately and contact your health care provider for further advice. A warm sensor could mean there is an infection or a sensor malfunction and should beremoved.
EVERSENSE CONTINUOUS GLUCOSE MONITORING Important Update: August 10, 2020. Senseonics announces agreement to collaborate with Ascensia Diabetes Care. Today we announced the signing of a collaboration and commercialization agreement between Senseonics, Incorporated, maker of the Eversense® brand of continuous glucose monitoring systems, and Ascensia Diabetes Care (Ascensia), maker of the CONTOUR® portfolio ofSAFETY INFORMATION
The Eversense CGM System is indicated for continually measuring glucose levels in adults (18 years and older) with diabetes for up to 90 days. It is designed to replace blood glucose testing for diabetes treatment decisions. The system is intended to: Provide real-time glucose readings. Provide glucose trend information. CONTACT US | EVERSENSE CONTINUOUS GLUCOSE MONITORING Contact us if you have questions/comments/concerns about the Eversense Continuous Glucose Monitoring System, our technology, or datamanagement.
FIND AN AUTHORIZED PROVIDER Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products.APP COMPATIBILITY
Some operating system updates may result in a need for a supporting update to the Eversense Mobile Apps. Once we have verified compatibility of new operating systems with Eversense, we will post them to this web page. Additionally, we recommend not using betaversions of
EVERSENSE XL
Eversense XL is the world’s first long-term CGM, with exceptional accuracy and a fully implantable sensor that lasts for up to 180 days. It can help you better manage your diabetes 1 by providing real-time insight into your changing glucose levels, which you can discreetly check on your compatible mobile device. People using Eversense say it helps them feel more confident about EVERSENSE CGM QUICK REFERENCE GUIDE The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. CODING AND BILLING QUICK REFERENCE GUIDE Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. TRAINING PROGRAM AND CERTIFICATION The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. QUICK REFERENCE GUIDE Cautions (continued) • If the sensor, insertion site or smart transmitter feels warm, remove the smart transmitter immediately and contact your health care provider for further advice. A warm sensor could mean there is an infection or a sensor malfunction and should beremoved.
EVERSENSE XL
Eversense XL is the world’s first long-term CGM, with exceptional accuracy and a fully implantable sensor that lasts for up to 180 days. It can help you better manage your diabetes 1 by providing real-time insight into your changing glucose levels, which you can discreetly check on your compatible mobile device. People using Eversense say it helps them feel more confident about EVERSENSE USER GUIDES The Eversense DMS is a web-based application that lets you see the big picture—with automatic uploads from your mobile app. It stores your data and offers detailed reports to show trends and patterns over time¹. 1. The Eversense Data Management System does not providemedical advice.
END-USER LICENSE AGREEMENT Patients of Senseonics Products and Services . If you are a patient utilizing Senseonics Products and Services, please note that you must obtain certain Senseonics continuous glucose monitoring (CGM) equipment (“ Equipment ”) from a healthcare provider or supplier pursuant to a valid prescription. The Software you are using (forexample
EVERSENSE USER GUIDES Eversense XL CGM User Guide - British English, UK. Click here to download the latest version. Archive: Mar 2019 Archive.pdf. Oct 2018 Archive.pdf. Feb 2018 Archive - 2.pdf. Feb 2018 Archive - 1.pdf. Sep 2017 Archive.pdf. Aug 2017 Archive.pdf. TRAINING, LEARNING, CLINICAL PRACTICE step-two-block step-one-title. Through a series of online videos, staff and physicians learn about the insertion and removal procedures and how to create a sterile field for the Eversense CGM System. Training is less than 30 minutes. VIDEO. HEALTH CARE PROVIDER USER GUIDES Eversense Insertion and Remove Instruction. Review this step-by-step guide on how to place and remove an Eversense sensor. After appropriate training, in office sensor placement takes less than 15 minutes. Physicians, nurse practitioners and physicians’ assistants can all receive training. Download. EVERSENSE® CGM SYSTEM DISTRIBUTOR LIST MKT-001489 rev 1 . To place your order, check order status and billing questions, please contact your distributor directly. Below please find our distributor contact list. EVERSENSE PLACEMENT AND REMOVAL TRAINING VIDEOS Learn how to place a new Eversense Sensor and remove a previous sensor. This video gives you step-by-step guidance, along with best practices for placement, closure and removal techniques. TAKE HOME INSTRUCTIONS Incision care for proper healing • Do not swim or soak in a tub for five days • Avoid strenuous activities that may pull at the incision or cause a lot of sweating around the EVERSENSE DATA MANAGEMENT SYSTEM (DMS) USER GUIDE The Eversense DMS is a web-based application that lets you see the big picture—with automatic uploads from your mobile app. It stores your data and offers detailed reports to show trends and patterns over time¹. 1. The Eversense Data Management System does not provide medical advice. Changes to your treatment plan should only be made by your health care provider. EVERSENSE CONTINUOUS GLUCOSE MONITORING Important Update: August 10, 2020. Senseonics announces agreement to collaborate with Ascensia Diabetes Care. Today we announced the signing of a collaboration and commercialization agreement between Senseonics, Incorporated, maker of the Eversense® brand of continuous glucose monitoring systems, and Ascensia Diabetes Care (Ascensia), maker of the CONTOUR® portfolio ofSAFETY INFORMATION
Review our indications and safety information to ensure the safe operation and use of the Eversense CGM System for continuous bloodglucose monitoring.
CONTACT US | EVERSENSE CONTINUOUS GLUCOSE MONITORING Contact us if you have questions/comments/concerns about the Eversense Continuous Glucose Monitoring System, our technology, or datamanagement.
FIND AN AUTHORIZED PROVIDER Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. EVERSENSE USER GUIDES The Eversense DMS is a web-based application that lets you see the big picture—with automatic uploads from your mobile app. It stores your data and offers detailedAPP COMPATIBILITY
View compatibility requirements here for the Eversense Mobile App and Data Management System. Check if your device is compatible for continuous glucose monitoring (CGM). END-USER LICENSE AGREEMENT View the End-User License Agreement for patients and non-patients that use software for the Eversense Continuous Glucose Monitoring System. CODING AND BILLING QUICK REFERENCE GUIDE Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. TRAINING, LEARNING, CLINICAL PRACTICE To begin learning about being an authorized Eversense CGM provider, see details about the five steps that include training, patient scheduling, and product ordering. EVERSENSE PLACEMENT AND REMOVAL TRAINING VIDEOS Learn how to place a new Eversense Sensor and remove a previous sensor. This video gives you step-by-step guidance, along with best practices for placement, closure and removal techniques. EVERSENSE CONTINUOUS GLUCOSE MONITORING Important Update: August 10, 2020. Senseonics announces agreement to collaborate with Ascensia Diabetes Care. Today we announced the signing of a collaboration and commercialization agreement between Senseonics, Incorporated, maker of the Eversense® brand of continuous glucose monitoring systems, and Ascensia Diabetes Care (Ascensia), maker of the CONTOUR® portfolio ofSAFETY INFORMATION
The Eversense CGM System is indicated for continually measuring glucose levels in adults (18 years and older) with diabetes for up to 90 days. It is designed to replace blood glucose testing for diabetes treatment decisions. The system is intended to: Provide real-time glucose readings. Provide glucose trend information. CONTACT US | EVERSENSE CONTINUOUS GLUCOSE MONITORING Contact us if you have questions/comments/concerns about the Eversense Continuous Glucose Monitoring System, our technology, or datamanagement.
APP COMPATIBILITY
Some operating system updates may result in a need for a supporting update to the Eversense Mobile Apps. Once we have verified compatibility of new operating systems with Eversense, we will post them to this web page. Additionally, we recommend not using betaversions of
FIND AN AUTHORIZED PROVIDER Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. EVERSENSE USER GUIDES The Eversense DMS is a web-based application that lets you see the big picture—with automatic uploads from your mobile app. It stores your data and offers detailed reports to show trends and patterns over time¹. 1. The Eversense Data Management System does not providemedical advice.
END-USER LICENSE AGREEMENT Patients of Senseonics Products and Services . If you are a patient utilizing Senseonics Products and Services, please note that you must obtain certain Senseonics continuous glucose monitoring (CGM) equipment (“ Equipment ”) from a healthcare provider or supplier pursuant to a valid prescription. The Software you are using (forexample
CODING AND BILLING QUICK REFERENCE GUIDE Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. TRAINING, LEARNING, CLINICAL PRACTICE step-two-block step-one-title. Through a series of online videos, staff and physicians learn about the insertion and removal procedures and how to create a sterile field for the Eversense CGM System. Training is less than 30 minutes. VIDEO. EVERSENSE PLACEMENT AND REMOVAL TRAINING VIDEOS Learn how to place a new Eversense Sensor and remove a previous sensor. This video gives you step-by-step guidance, along with best practices for placement, closure and removal techniques.EVERSENSE XL
Eversense XL is the world’s first long-term CGM, with exceptional accuracy and a fully implantable sensor that lasts for up to 180 days. It can help you better manage your diabetes 1 by providing real-time insight into your changing glucose levels, which you can discreetly check on your compatible mobile device. People using Eversense say it helps them feel more confident about EVERSENSE USER GUIDES The Eversense DMS is a web-based application that lets you see the big picture—with automatic uploads from your mobile app. It stores your data and offers detailed reports to show trends and patterns over time¹. 1. The Eversense Data Management System does not providemedical advice.
HCP HOME PAGE
The Eversense®XL Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 180 days. It is intended to complement, not replace, fingerstick blood glucose monitoring. The sensor insertion and removal procedures are performed by a health careprovider.
END-USER LICENSE AGREEMENT Patients of Senseonics Products and Services . If you are a patient utilizing Senseonics Products and Services, please note that you must obtain certain Senseonics continuous glucose monitoring (CGM) equipment (“ Equipment ”) from a healthcare provider or supplier pursuant to a valid prescription. The Software you are using (forexample
EVERSENSE USER GUIDES Eversense XL CGM User Guide - British English, UK. Click here to download the latest version. Archive: Mar 2019 Archive.pdf. Oct 2018 Archive.pdf. Feb 2018 Archive - 2.pdf. Feb 2018 Archive - 1.pdf. Sep 2017 Archive.pdf. Aug 2017 Archive.pdf. EVERSENSE® CGM SYSTEM DISTRIBUTOR LIST MKT-001489 rev 1 . To place your order, check order status and billing questions, please contact your distributor directly. Below please find our distributor contact list. HEALTH CARE PROVIDER USER GUIDES Eversense Insertion and Remove Instruction. Review this step-by-step guide on how to place and remove an Eversense sensor. After appropriate training, in office sensor placement takes less than 15 minutes. Physicians, nurse practitioners and physicians’ assistants can all receive training. Download. TAKE HOME INSTRUCTIONS Incision care for proper healing • Do not swim or soak in a tub for five days • Avoid strenuous activities that may pull at the incision or cause a lot of sweating around the TRAINING PROGRAM AND CERTIFICATION The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. REGISTER FOR TRAINING Senseonics, Incorporated is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Skip to main content×
IMPORTANT UPDATE: AUGUST 10, 2020 Senseonics announces agreement to collaborate with Ascensia DiabetesCare
Today we announced the signing of a collaboration and commercialization agreement between Senseonics, Incorporated, maker of the Eversense® brand of continuous glucose monitoring systems, and Ascensia Diabetes Care (Ascensia), maker of the CONTOUR® portfolio of blood glucose monitoring systems. This collaboration will help more people living with diabetes gain access to the Eversense CGM technology, with Ascensia taking responsibility for sales, marketing, and distribution of Eversense products in the US, effective in 2021. In advance of this date, Ascensia will begin to work alongside us on initial sales and marketing activities in 2020. We are excited to be partnering with Ascensia, a global diabetes technology company that is a leader in the blood glucose monitoring market. Ascensia has a legacy of almost 80 years in diabetes care and shares the same passion and commitment to delivering highly accurate and state-of-the-art products for people with diabetes. We will continue providing the Eversense CGM system you have come to trust and rely on, as the only long term CGM system in the world. Going forward, Senseonics will continue to innovate our technology, including bringing advanced Eversense products with extended-life sensors to the US market upon FDA approval. Together, we are working to plan and execute a smooth transition to ensure minimal disruption to you and your healthcare provider, including for your next sensor placement this year. In the near future, the sales, marketing and customer support function will be transferred to Ascensia with full support and guidance by our Senseonics team members. To read the press release, go to https://www.senseonics.com/investor-relations/news-releases/2020. More information will be forthcoming from both Senseonics and Ascensia through our respective company websites, social media platforms, as well as direct messages to you, our valued users. We are committed to communicating openly with you as we move forward. If you have any questions or need assistance, please contact us at support@eversensediabetes.com, or visit https://www.eversensediabetes.com/ for updates. As always, our Customer Care team is available 24/7 to assist you at 844-SENSE4U(736-7348).
We look forward to a bright future with our collaboration with Ascensia and our ability to help you along your journey with diabetes. We thank you for your unwavering support of Eversense during this time of the global pandemic.Sincerely,
Francine Kaufman, MD and the Senseonics Leadership Team To read the press release, click here.
To learn more about Ascensia Diabetes Care, click here.
FREQUENTLY ASKED QUESTIONS * CAN YOU TELL ME MORE ABOUT ASCENSIA AS A COMPANY? * Ascensia Diabetes Care is a growing global market leader offering premium, connected blood glucose monitoring systems and testing supplies to customers in over 125 countries. Their CONTOUR BGM utilizes advanced technology to provide leading accuracy and ease of use while integrating with several diabetes management apps to provide a premium user experience. They have apps and software to help with diabetes management and the meter links to some insulin pumps. * WHY WAS IT IMPORTANT FOR SENSEONICS AND ASCENSIA TO HAVE THISCOLLABORATION?
* The collaboration helps ensure patients worldwide can more easily access and benefit from Eversense – Senseonics has the technology and Ascensia has the commercial infrastructure to make it happen, and both organizations are committed to making life with diabetes easier. * WHO DO I CONTACT FOR SUPPORT? * We will have the same numbers, website and support through Customer Care that we have now. We will continue to be available 24/7. * WHO DO I CALL FOR MY NEXT SENSOR? * There are no changes to the ordering process. Please reference the FAQs below for additional information about continuing with Eversense. * HOW DO I ORDER MY NEXT SENSOR? * Our distributor partners are open! Please reach out to your distributor directly. For contact information, click here.
* If you do not remember the distributor you last worked with, you can look at your recent Eversense invoices or a recent EOB (Explanation of Benefits) from your insurance company. Also, be on the lookout for a text/email from us 30 to 45 days before your sensor is due for replacement. Of course, if you have questions at any time, please call us at 844-SENSE4U. * IS THE EVERSENSE BRIDGE PROGRAM STILL ACTIVE AND CAN I PARTICIPATE IN THE PROGRAM BEYOND MY 2ND SENSOR? * The Eversense Bridge Program has been extended to continue helping eligible patients with out-of-pocket costs for the Eversense product. This extension goes beyond your 2nd sensor! * As a reminder, the Eversense Bridge Program covers the cost of the sensor product only. The sensor insertion/removal procedure has a separate cost – please inquire with your HCP regarding fees associated with the procedure. * WHAT ABOUT OTHER SENSEONICS PATIENT ACCESS PROGRAMS – ARE THEYAVAILABLE?
* There have been significant changes to certain patient programs that previously may have covered the costs of sensor insertions and removals. Please make sure to inquire with your HCP regarding costs associated with these procedures. * WHAT IF MY INSERTING HEALTH CARE PROVIDER’S OFFICE IS CLOSED DUE TO COVID-19 OR NO LONGER PROVIDING EVERSENSE IN THEIR PRACTICE? * We have Certified Eversense providers throughout the country who might be able to help you! * If you require help locating an available provider, call 844-SENSE4U or email HCPservices@senseonics.com. * If you are due for a sensor replacement but would rather wait for your own HCP or are experiencing travel restrictions due to COVID-19, do not worry - the sensor can stay in your arm safely past the 90-day wear time. However, you will not receive any readings once you have reached the 90-day wear time period. IF YOU HAVE ANY BILLING QUESTIONS, PLEASE CONTACT YOUR DISTRIBUTOR OR YOUR HEALTH CARE PROVIDER. IF YOU HAVE PRODUCT QUESTIONS OR A TROUBLESHOOTING NEED, CALL EVERSENSE CUSTOMER CARE AT 844-SENSE4U – WE ARE HERE TO HELP 24/7!Thank you,
The Eversense Team
To learn more about the Eversense CGM System, click here.COVID-19
Update
Eversense USA
Eversense USA Eversense Outside USA To learn more about the Eversense CGM System, click here.COVID-19
Update
PATIENT - HEADER - MAIN MENU - DESKTOP* Compatibility
* User Guides
* Eversense Users
* Health Care Providers* Contact Us
* About Us
* Accessibility
* Get Started
MOBILE MAIN NAVIGATION* Compatibility
* User Guides
* Eversense Users
* Health Care Providers* CONTACT US
* About Us
Eversense USA
Eversense USA Eversense Outside USA*
90 DAYS TO
BE UNSTOPPABLE
DAY 56 - SOMEWHERE IN CALIFORNIA With Eversense, the only FDA-approved, long-term continuous glucosemonitor
Learn More
WATCH VIDEO
*
ROBERT
EVERSENSE® CGM USERLEARN MORE
WATCH VIDEO
Slide #2
Slide #2
Paragraphs
THE EVERSENSE CGM SYSTEMLet’s Get Started
Selector Id
eversense-cgm-systemSelector Class
eversense-cgm-systemx
RIGHT -FIXED MENU HOME PAGE* Call
__ __
__
__
__
GLOBAL - FOOTER - TOP MENU * 844-SENSE4U (736-7348)* email us
WHO WE ARE
Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. Our mission is to help people with diabetes live their lives confidently and with ease.Senseonics, Inc.
EVERSENSE DIABETES WEBSITEEversense USA
Eversense USA Eversense Outside USA PATIENT - FOOTER MENU - COLUMN FOUR* CONTACT US
* ABOUT US
* How we started
* What we believe
* DMS LOGIN
DISCLAIMER
The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration twice per day, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense CGM System is a prescription device; patients should talk to their health care provider to learn more. For important safety information, see https://eversensediabetes.com/safety-info/. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin. MKT-5143-01-001 Rev 3 FOOTER MENU - COPYRIGHT * © 2019 Senseonics, Incorporated* EULA
* Privacy Policy
* Legal
* Safety
* Contact Us
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0